Carl Zeiss Meditec falls after GS cuts to 'sell' on valuation concerns
05/10/2026 08:41
BUZZ-Carl Zeiss Meditec falls after GS cuts to 'sell' on valuation concerns ** Carl Zeiss Meditec's AFXG.DE shares fall around 4% after Goldman Sachs cut its rating on the medical technology company to "sell" from "neutral", citing a disconnect between valuation and growth prospects
** GS says the stock has rerated despite a deteriorating outlook and meaningful earnings estimate cuts
** It believes the rerating was partly driven by Carl Zeiss Group's June announcement to invest up to €200 million to increase its stake in the company
** As that buying support fades, GS expects the gap between valuation and underlying fundamentals to close
** Cuts its PT on the stock to €23 from €27
($1 = 0.8941 euros)
(Reporting by Kira Britten)
Recent news on Carl Zeiss Meditec AG
See all newsEurope Research Roundup: Bankinter, Santander, Volex
Corrected: ANALYSIS-ASML's 'sold out' outlook forces investors to look beyond demand
Brief: Carl Zeiss Meditec Acquires Ceres Holographics
Carl Zeiss Meditec falls after GS cuts to 'sell' on valuation concerns
Brief: Zeiss Clinic 360 Receives FDA 510K Clearance, Amplifying Patient Care Through Simplified Clinical Insights